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The ability to subvert intracellular antiviral defenses is necessary for virus to survive as its replication occurs only in the host cells.
Viruses have to modulate cellular processes and antiviral mechanisms to their own advantage during the entire virus life cycle.
Autophagy plays important roles in cell regulation. Its function is not only to catabolize aggregate proteins and damaged organelles
for recycling but also to serve as innate immunity to remove intracellular pathogenic elements such as viruses. Nevertheless,
some viruses have evolved to negatively regulate autophagy by inhibiting its formation. Even more, some viruses have employed
autophagy to benefit their replication. To date, there are more and more growing evidences uncovering the functions of many viral
proteins to regulate autophagy through different cellular pathways. In this review, we will discuss the relationship between viruses
and autophagy and summarize the current knowledge on the functions of viral proteins contributing to affect autophagy process.
1. Introduction
Autophagy is an intracellular degradative process including
macroautophagy, microautophagy, and chaperone-mediated
autophagy (CMA) [1]. In this review, we focus on the
regulation of viral proteins in microautophagy (referred here
as autophagy) process. Autophagy can take place in amanner
of selected or nonselected catabolic process via the lysosomal
pathway as compared to ubiquitin-proteasome degradation.
Under starvation stress, autophagy provides the energy
source for cell survival by degradation of the unwanted sub-
stance. Besides, autophagy is responsible for removing the
damaged organelles caused by reactive oxygen species (ROS)
[2]. Impaired autophagy had been found closely related to
manypathological conditions, such as neurological disorders,
aging, diabetes, and cancer [3]. Autophagy is also involved in
the innate and adaptive immunity system to resist pathogen
infection by viruses and bacteria [4, 5].
Many signaling pathways are involved in activation of
autophagy. The mammalian target of rapamycin (mTOR)
is one of the main negative mediators of autophagy.
While the upstream negative regulators of mTOR such as
phosphatase and tensin deleted on chromosome 10 (PTEN),
AMP-activated protein kinase (AMPK), p53, eukaryotic
translation initiation factor 2𝛼 (eIF2𝛼), and c-jun-N-terminal
kinase (JNK1) in turn function as activators of autophagy
[6]. When mTOR is repressed, the interaction between
mTOR and ULK1 (Atg1) become weak, therefore, resulting in
hypophosphorylation of ULK1 as well as Atg13.The activated
hypophosphorylated ULK1 is then associated with Atg13 and
Atg17 to form a complex that promotes the initial stage of
autophagy [7]. During this initiation step of autophagy, the
Beclin 1 formed the complex with Vps34 and Atg14 that was
essential for phagophore formation [8].Members of the Bcl-2
family acted as inhibitors in this stage [9]. In the second step,
elongation of the isolated membrane triggered the formation
of double-layer phospholipid membrane that can engulf
organelles. Activations of Atg7 and Atg10 catalyzed the for-
mation of Atg12-Atg5-Atg16 complex [10]. On the other hand,
the C-terminal arginine 117 residue of newly synthesizedAtg8
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is initially cleaved by the Atg4 in order to expose a glycine
residue [11]. The Gly-terminal residue of Atg8 is then bound
to the active cysteine 507 of Atg7 and then activated by Atg7
(an E1-like enzyme). The activated Atg8 is then transferred
to another E2-like enzyme (Atg3). Finally, Atg8 is conjugated
to the phosphatidylethanolamine (PE) by an amide bond
between the C-terminal glycine of Atg8 and the amino group
of PE [12]. Both of these two conjugation systems were
important in promoting the elongated membrane curvature,
thereby, resulting in the autophagosome formation.The third
step of autophagy was the docking and fusion of autophago-
some with lysosome through the assistances of LAMP2 and
Rab7 proteins [13]. The inner membrane of autophagosome
and organelles that were engulfed earlier were broken down
into small molecules by lysosome enzymes such as cathepsins
B, D, and L [3]. Finally, those small molecules were exported
to cytoplasm and recycled as new sources for further uses.
Recently, growing numbers of studies have discovered
that autophagy seems to involve in life cycle of some viruses.
It is not surprised that xenophagy, a form of autophagy, is the
cellular intrinsic immune system against viruses. Therefore,
the suppression in autophagy provides virus with a way
to overcome the cellular defense mechanisms. Vesicular
stomatitis virus (VSV) inhibits cellular autophagy to facilitate
viral replication in infected cells [14].The elevated expression
of Beclin 1 resulted in reduction of virus replication of both
herpes simplex virus type 1 (HSV-1) and sindbis virus [15, 16].
Human cytomegalovirus (HCMV) and simian immunodefi-
ciency virus type 1 (SIV 1) both had been reported to inhibit
autophagy through different strategies [17–19]. Even though
the autophagy is thought to be an intracellular antiviral
system, however, numbers of viruses have been found to acti-
vate autophagy instead of repression. Previous studies have
indicated that infections of Epstein-Barr virus (EBV) and
varicella zoster virus (VZV) caused induction of autophagy
[20, 21]. Furthermore, avian reoviruses (ARVs), coxsack-
ievirus B3 (CVB3), dengue virus, hepatitis C virus (HCV),
and influenza A virus (IAV) not only induced autophagy
but also upregulated autophagy to enhance virus replication
[22–26]. Interestingly, human immunodeficiency virus type
1 (HIV-1) suppresses the late stages of autophagy [27];
however, it has been reported that autophagy-related genes
appear to facilitate HIV infection [28]. The different stages
of autophagy might play different roles in virus life cycles.
Formation of autophagosomes has been proposed to offer
the platform for viral replication and viral assembly, like
HIV-1 [18, 29]. Degradation of the lipids in the late stage of
autophagy can provide the energy source for viral replication
as dengue virus (DENV) [30]. Some viruses, like CVB3,
trigger incomplete autophagy flux for their own benefits [3].
Furthermore, it has been reported that ARV triggers the
fusion of autophagosome with lysosome into autolysosome
without completing the autophagy flux [22]. How the virus
regulates this incomplete autophagy process and what kinds
of advantage this process brings to viruses still remain
unclear.
Table 1: Role of the viral proteins in regulation of autophagy.
Viral protein Virus
Activator or
suppressor of
autophagy
References
DP71L ASFV Sa [45]
p17 ARV Ab [22]
nsP2 CHIKV A [66]
nsP4 CHIKV S [85]
LMP-1 EBV A [82]
HBs HBV A [81]
HBx HBV A [38]
TRS1 HCMV S [36]
PUL38 HCMV A [80]
E1 protein HCV S [84]
Nef HIV-1 A [18, 72]
Glycoprotein B HSV-1 S [76]
ICP34.5 HSV-1 S [43]
Us11 HSV-1 S [48, 49, 51, 52]
vFLIP HVS/KSHV/MCV S [60]
M2 protein IAV A [67]
v-cyclin KSHV A [81, 86]
vBcl-2 KSHV/𝛾HV-68 S [9]
m142 & m143 MCMV S [53, 54]
IE180 PRV S [44]
nsP4 Rotavirus A [70, 71]
S protein SARS-CoV A [77, 78]
Small T antigen SV40 A [73, 74]
aS: suppressor; bA: activator.
2. The Contributions of Viral
Proteins in Regulating Signaling
Pathways of Autophagy
Many viral proteins have been demonstrated to play impor-
tant roles in autophagy regulation either by interacting with
autophagy-related proteins or by modulating the signaling
pathways that affect the autophagy. Here we will focus on
the regulations of Beclin 1/Vps34 complex, PKR/eIF2𝛼 sig-
naling pathway, the autophagy pathways, mTOR signaling
pathway, and cytoprotective signaling pathways and briefly
summarize the roles of these well-characterized viral proteins
in regulation of autophagy, as shown in Table 1.
2.1. Regulation of Beclin 1/Vps34 Complex
2.1.1. The Bcl-2-Like Viral Protein. HSV-1 is a 152 kb double-
stranded DNA virus, belonging to the 𝛼-herpesvirus family.
HSV-1 negatively regulates autophagy during infection [31].
The 𝛾
1
34.5 gene of HSV-1 encodes ICP34.5 protein, con-
sisting of 263 amino acids. This protein has three domains
including an N-terminal region, a linker region of Ala-Thr-
Pro repeats, and a C-terminal region [32, 33]. It regulates
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cellular autophagy via two distinctive mechanisms. The N-
terminal region of ICP34.5 possesses a Beclin 1 binding
domain, which mimics the inhibitory effect of the cellular
Bcl-2 protein, thereby, preventing Beclin 1 to bind with
the PI3KC3- (phosphoinositide 3-kinase class III-) UVRAG
(UV irradiation resistance-associated gene) complex. Beclin
1 is a critical component of PI3KC3 complex that triggers
the initiation of autophagy, and its function is suppressed
through interaction of Bcl-2 with the BH3 domain of Beclin
1 [34]. The HCMV protein TRS1 and the viral homologues of
Bcl-2 of Kaposi’s sarcoma herpesvirus (KSHV) and murine
gamma herpesvirus 68 (𝛾HV-68) have been also shown
to inhibit the formation of autophagosomes through their
binding to Beclin 1 [9, 35, 36].
2.1.2.TheHepatitis BVirus XProtein (HBx). HBV is a double-
strand DNA virus, a member of the hepadnavirus family.
Its DNA genome contains four genes named S, C, P, and X,
respectively. The HBx protein encoded by the X gene serves
as a multifunctional regulatory protein since it is involved
in regulating cell cycle, signaling transduction, and cellular
apoptotic pathways [37]. HBV can enhance autophagic flux
in cell culture and transgenic mouse liver and during natural
infection. Enhancement of autophagy caused by HBV is now
believed by the contribution of HBx [38]. In accordance with
the results of coimmunoprecipitation assays performed by Sir
et al., it was discovered that HBx can directly bind to Vps34,
the catalytic subunit of PI3KC3, to promote the activity of
PI3KC3. The HBx-induced autophagy benefits HBV DNA
replication rather than RNA transcription. Furthermore,
autolysosomes were not involved in HBV replication, since
treatment of cells with bafilomycin to suppress formation of
autolysosomes showed no effects on HBV DNA replication
[38].
2.2. Regulation of PKR/eIF2𝛼 Signaling Pathway
2.2.1. The Regulators of Protein Phosphatase 1 (PP1). In
addition to inhibition of autophagy by binding to Beclin
1, ICP34.5 can also regulate autophagy through regulation
of eIF2𝛼. eIF2𝛼 plays a central role in the maintenance
of mRNA translation. Phosphorylation of eIF2𝛼 at Ser51
shuts off protein translation and stimulates autophagy [39];
therefore, eIF2𝛼 can be regarded as amodulator of autophagy.
The C-terminal region of ICP34.5 contains a consensus
bindingmotif (R/KVXF) for PP1 followed by an Ala-Arg-rich
motif, that is, highly homologous to the C-terminal region
of mammalian growth arrest and DNA damage protein 34
(GADD34) [40–42]. More recently, the amino acids residues
233–248 in the ICP34.5 (homology region of GADD34)
were verified as a binding site of eIF2𝛼. It has been also
demonstrated that the binding between ICP34.5 and eIF2𝛼 is
crucial for specific dephosphorylation of eIF2𝛼 by PP1, thus
facilitating the initiation of protein translation and, as a result,
suppressing autophagy [43]. The African swine fever virus
(ASFV) DP71L protein and the pseudorabies virus (PRV)
IE180 protein act similarly to ICP34.5 to abolish phosphory-
lation of eIF2𝛼 by regulating PP1 [44, 45].
2.2.2. Us11. Us11, a late 𝛾2 gene product, is a viral protein
abundantly produced in the late stage of HSV-1 life cycle.
Like ICP34.5, Us11 is involved in inhibition of eIF2𝛼 phos-
phorylation. Earlier studies have shown that Us11-null viruses
grow normally in vitro and are slightly attenuated in vivo,
suggesting that the function of Us11 may be compensated by
the extant ICP34.5 [46, 47]. Nevertheless, Us11 acts in concert
with ICP34.5 to inhibit autophagy through a mechanism
totally different from that in which ICP34.5 is involved. Us11
blocks the kinase activity of protein kinase R (PKR) via
directly binding to either PKR or upstream activators of PKR.
Since eIF2𝛼 is the substrate of PKR, the PKR binding domain
located between amino acids residues 91–121 close to the
C-terminus of Us11 contributes to physical association with
PKR, resulting in a reduction of eIF2𝛼 phosphorylation [48].
A previous investigation demonstrated that the truncated
Us11 mutants without its N-terminus failed to inhibit poly-
(I⋅C-) induced autophagy in HeLa cells stably expressing
GFP-LC3, indicating that the N-terminal region of Us11 is
critical for inhibition of autophagy [49].
It has been well-known that PKR is transcriptionally
induced by interferon and activated by double-stranded RNA
(dsRNA). The C-terminus of Us11 contains an Arg/Pro-rich
RNA binding domain (amino acids residues 91–152), which
can bind to dsRNA to dampen the stimulation of PKR [50]. In
addition, Us11 also can interact with activators of interferon,
including retinoic acid-inducible gene I (RIG-I), melanoma-
associated differentiation gene 5 (MDA-5), and the protein
activator of the interferon-induced protein kinase (PACT), to
inhibit the production of interferon through its C-terminal
RNA binding domain [51, 52].
2.2.3. Murine Cytomegalovirus (MCMV) m142 and m143
Proteins. MCMV is a DNA virus in theHerpesviridae family.
MCMV gene expression and/or viral replication can cause
accumulation of dsRNA in infected cells. However, activa-
tion of the PKR-mediated antiviral response by dsRNA is
counteracted by viralm142 andm143 proteins duringMCMV
infection. Both m142 and m143 proteins are important for
MCMV replication and both of them are essential for inhi-
bition of PKR and subsequent eIF2𝛼 phosphorylation [53].
To exert its role in inactivating PKR, m142 associates with
m143 to form a stable heterotetramer complex including two
molecules of m142, and each one binds to a monomer of
m143.Them142-m143multimer directly binds to PKR as well
as to dsRNA to prevent PKR activation, resulting in relo-
calization of PKR into the nucleus and into an insoluble
cytoplasmic compartment. Thus, PKR is unable to shut off
cellular translation and to repress viral replication [54].
2.2.4. ARV Nonstructural Protein p17. ARVs are double-
strand RNA viruses that are classified as the members of
Reoviridae family. ARV enters host cells via the caveolin 1-
mediated endocytic pathway [55] and its replication occurs in
the cytoplasmof infected cells [56].Thenonstructural protein
p17 is encoded by the S1 genome segment of ARV with 146
amino acids [57]. It shuttles between the nucleus and the cyto-
plasm to affect signaling pathways involved in cell growth,
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paving away for effective viral production [58, 59]. Our group
has demonstrated that p17 is the protein responsible for ARV-
induced host cell cycle arrest and autophagosome formation
[22, 59]. Ectopically expression of p17 in both immortal-
ized chicken embryo fibroblast (DF-1) cells and African
green monkey kidney (Vero) cells by transfection with
a p17-expressing plasmid caused phosphorylation of eIF2𝛼
that led to induction of autophagy [22]. It was also demon-
strated that p17 triggered autophagy via activations of PTEN
and AMPK to negatively regulate the function of mTORC1
[22]. We therefore considered that the p17 protein serves as
an autophagy inducer in the life cycle of ARV.
2.3. Regulation of Autophagy Pathway
2.3.1. The cFLIP-Like Viral Protein. Some 𝛾-herpesvirus
encode a viral protein homologous to the cellular FLICE-like
inhibitor protein (cFLIP), such as KSHV vFLIP, herpesvirus
saimiri (HVS) vFLIP, and molluscum contagiosum virus
(MCV) 159L [60]. The cFLIP protein that has been identified
exists in 3 forms based on their variable C-terminus. It also
contains 2 death effector domains (DED) at the N-terminus.
The FLIP is involved in negative regulation of cellular apop-
tosis induced by the activation of specific proapoptotic recep-
tors on the cell surface, including Fas/CD95, DR4, and DR5
death receptors that associate with TNF-𝛼-related apoptosis-
inducing ligand (TRAIL), and tumor necrosis factor-𝛼 recep-
tor 1 (TNFR1). Moreover, these ligand-receptor complexes
interact with tumor necrosis factor receptor type 1-associated
death domain protein (TRADD) and Fas-associated protein
with death domain (FADD) to form the death-inducing
signaling complex (DISC) which in turn activates the down-
stream caspase signaling cascade to induce apoptosis [61].
Due to structural similarity of FLIP to procaspase-8, which
is as the initiator caspase in the caspase-dependent pathways,
FLIP forms a heterodimer with procaspase-8, which becomes
inactive, and therefore limiting the amount of procaspase-8
binding to DISC [62].
A recent study has unveiled another role of vFLIP in
autophagy regulation. vFLIP can block cellular autophagy by
binding Atg3 E2-like enzyme with its DEDs. Atg3 is a critical
enzyme that mediates lipidation and conjugation of LC3
to promote autophagosome biogenesis. Interaction between
vFLIP and Atg3 prevents LC3 from binding with Atg3. As
a result, a reduction of autophagy occurs in virus-infected
cells [60]. Exemplified by KSHV, a model was consequently
proposed that it expresses vFLIPwithin viral latency program
to subvert autophagy and to facilitate its own replication in
virus-infected cells. Despite the ability of vFLIP binding
to Atg3 to inhibit autophagy, Ritthipichai et al. have recently
reported that rhesus monkey rhadinovirus vFLIP can
enhance the autophagosome formation via an unknown
mechanism in order to inhibit cellular apoptosis [63]. The
functions of vFLIP expressed by different viruses seem
somehow manifold in regulation of cell proliferation.
2.3.2. CHIKV nsP2 Protein. CHIKV is an enveloped virus
with a positive-strand RNA genome belonging to the
Alphavirus genus. It triggers an autophagy response in
infected human-cultured cells to promote viral replication
[64]. CHIKVencodes 4 nonstructural proteins (nsP1 to nsP4)
which are important for virus replication. During infection,
nsPs bind to viral RNA to form replicative complexes (RC),
thereby resulting in RCs to anchor into the subcellular mem-
branes situated around the nucleus for viral protein synthesis.
Among these nsPs, the nsP2 had been identified as an essen-
tial component of RCs [65]. Furthermore, the nsP2 can use
the autophagy machinery to help virus replication through
the binding to the human autophagy receptor NDP52. The
experimental results of yeast two-hybrid system have shown
that the C-terminal domain of nsP2 is responsible for the
interaction with the coiled-coil domain of NDP52. In addi-
tion, it has been demonstrated that NDP52 colocalized with
the trans-Golgi network associated RCs containing nsPs and
dsRNA, while knockdown of NDP52 by using siRNA specific
to NDP52 strikingly decreased CHIKV replication [66].
These data described above provide evidences suggesting that
NDP52 can promote CHIKV replication via nsP2, although
the detailed mechanism remains unclear.
2.3.3. Viral Proteins That Interfere with the Progress of
Autophagy. Many viruses have evolved to trigger an incom-
plete autophagy response in virus-infected cells to benefit
their replications. For example, the M2 protein encoded by
IAV is sufficient to induce cellular autophagy response [67].
Nevertheless, it can also block the fusion between autophago-
somes and lysosomes, leading to accumulation of autophago-
somes. Study of M2 protein has provided a possible mecha-
nism in which blockade of autophagolysosome formation is
through the interaction of M2 protein to Beclin 1 [68, 69].
Such blockade may enhance the retention time of viral pro-
teins and RNA in infected cells. Rotavirus nsP4 protein can
induce autophagy as well, and it binds to autophagosomes to
prevent the autophagolysosome formation. The nsP4 protein
of rotavirus is likely to recruit autophagosomal membrane to
viroplasm to promote virus replication, wherein the viral
RNA is replicated [70, 71]. Similarly, HIV-1 induces the auto-
phagic vacuoles in macrophages during infection to enhance
its replication, and its Nef protein blocks the maturation of
autophagolysosomes to prevent Gag proteins from degrada-
tion [18, 72].
2.4. mTOR Signaling Pathway. Simian virus 40 (SV40) is a
DNA virus that belongs to Polyomaviridae family. SV40, like
other polyomaviruses, is potentially oncogenic (tumor caus-
ing). The small T antigen (ST) has 174 amino acid residues
encoded by the SV40 early region. Studies that focused
on the function of ST have linked the relationship between ST
and the mechanism by which cancer cells can survive under
condition of nutrient deprivation. ST binds to protein phos-
phatase 2A (PP2A), a primary serine/threonine phosphatase
in mammalian cells, with its C-terminal domain to form a
stable complex, disabling PP2A and resulting in disturbance
of cellular progress [73]. Under glucose deprivation, the
phosphorylation level of AMPK was increased in human
foreskin fibroblasts expressing ST, and the rate of cell death
was decreased in contrast to that of cells without expressing
ST [74].When AMPK is phosphorylated atThr172 to become
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an active form, it directly phosphorylates TSC2 at Sre1387 and
the mTORC1 subunit raptor at Ser722 and Ser792 to inhibit
cell growth, thus inducing autophagy pathways for energy
acquirement [75]. SV40 ST acts in cancer cells to maintain
energy homeostasis during glucose deprivation by inhibiting
the mTOR signaling pathway which is likely responsible for
activation of autophagy.
2.5. Regulation of Cytoprotective Signaling Pathways
2.5.1. The Unfolded Protein Response (UPR). UPR is an alarm
system for cells in response to the accumulation of unfolded
or misfolded proteins in the lumen of the endoplasmic retic-
ulum (ER), triggering formation of autophagy to digest and
clean these unwanted proteins. There are three main path-
ways activated upon UPR induction, including transcription
factor 6 (ATF6), PKR-like ER kinase (PERK), and inositol-
requiring kinase 1 (IRE-1) [76]. A number of viruses that have
been characterized encode proteins modifying autophagy
through UPR to their own advantages during infection.
For example, severe acute respiratory syndrome coronavirus
(SARS-CoV) modulates UPR by activating PERK protein
kinase by its viral spike (S) protein [77, 78], while the E
protein encoded by the envelope gene downregulates the IRE-
1 signaling pathway [79]. HCMV protein pUL38, like the
small surface protein (HBs) of HBV, is capable of activating
the key components of PERK pathway, including PERK,
eIF2𝛼, and transcription factor 4 (ATF4) [80, 81]. The
latent membrane protein 1 (LMP-1) of EBV upregulates all
three signaling pathways of UPR that have been described
previously [76, 82]. Moreover, West Nile virus requires ATF6
signaling for its replication, and a viral protein responsible for
regulatingATF6 signaling still remains to be determined [83].
On the contrary, HSV-1 glycoprotein B (gB), HCV cytosolic
envelope protein E1, and CHIKV nonstructural protein 4
(nsP4) suppress the PERK pathway during infections [76, 84,
85].
2.5.2. The DNA Damage Response (DDR). DDR, a cellular
self-protective mechanism, is responsible for detecting dam-
aged DNA. Activation of DDR causes cell cycle arrest and
initiates the DNA repair system, avoiding mutated DNA
duplication. DDR signaling is primarily controlled by ataxia
telangiectasia mutated (ATM), ATM and RAD3-related
(ATR), and DNA-dependent protein kinase (DNA-PK) [87].
The existence of a complex interrelationship between viral
infection and cellular DDR revealed that some viruses can
selectively activate and/or repress DDR signaling pathways
in a temporally coordinated manner to promote virus repli-
cation [87–91]. KSHV v-cyclin is one of the well-known
viral proteins that trigger autophagy indirectly via activation
of DDR. As the name implied, v-cyclin is homologous
to D-type cyclins that binds to cyclin-dependent kinase 6
(CDK6) to form an active holoenzyme, allowing v-cyclin to
constitutively deregulate cell cycle and to promote oncogenic
stress. This stress triggers the DDR signaling, resulting in
autophagy and cellular senescence [81, 86]. KSHV v-cyclin
is cotranscribed with the latency-associated nuclear antigen
(LANA) and vFLIP in a latent transcription unit, and it
cooperates with vFLIP to precisely control the autophagy
formation in KSHV-infected cells. This cooperation might
contribute to the phenomenon observed in KSHV latent
infection wherein the infected cells only have modest levels
of autophagy and fail to senesce, as reported by Leidal et al.
[92].
3. Conclusion
Due to the ability to degrade the pathogens from outer envi-
ronment, autophagy is also one of the protective mechanisms
against viruses that are harmful to the host. More and more
studies revealed that viruses have evolved diverse mecha-
nisms in order to evade from the defenses as autophagy. Nev-
ertheless, previous investigations also revealed that several
viruses induce autophagy to benefit themselves. The regula-
tion of autophagy is a procedure involving a series of steps
that require well-controlled signaling pathways. How the
viruses operate in this process in order to complete their
productive infection in host cells remain to be addressed.
Understanding of the roles of autophagy and autophagy-
related regulation in virus life cycle can raise the possibility
in developing more specific antiviral treatments. And even
more, the new findings might further support the therapies
for other autophagy-related diseases, such as neurodegener-
ative disorders and cancer.
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